Xiaobin Wu Sells $1.05M of BeiGene Ltd (BGNE) — SEC Form 4, Sep 05, 2024
Open-Market Net Sale · SEC Form 4
−$1,053,677
10b5-1 Plan
Equity position changed by -0.5%
Equity Position
1.15M sh
1,157,273 → 1,151,717
Equity Change
-0.5%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Xiaobin Wu CIK 0001739452 |
COO
|
Xiaobin Wu at BeiGene Ltd
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$8,753,697
More from this insider at BeiGene Ltd
| 2026-08-27 | Sell | -$106,400 | View |
| 2026-06-25 | Sell | -$356,927 | View |
| 2026-06-18 | Sell | -$361,997 | View |
| 2026-06-15 | Sell | -$163,512 | View |
| 2026-06-10 | Sell | -$399,738 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| American Depositary SharesF1F5F6 | 2024-09-03 | S - Sale 10b5-1 | 2,032 D | $188.16 | -$382,337 | 3,524 | Direct |
| American Depositary SharesF1F5F7 | 2024-09-03 | S - Sale 10b5-1 | 275 D | $188.97 | -$51,968 | 3,249 | Direct |
| American Depositary SharesF1F5F8 | 2024-09-03 | S - Sale 10b5-1 | 2,275 D | $190.29 | -$432,909 | 974 | Direct |
| American Depositary SharesF1F5F9 | 2024-09-03 | S - Sale 10b5-1 | 700 D | $191.20 | -$133,843 | 274 | Direct |
| American Depositary SharesF1F5F10 | 2024-09-03 | S - Sale 10b5-1 | 274 D | $192.04 | -$52,620 | 0 | Direct |
Footnotes (10)
- F1
- Each American Depositary Share represents 13 Ordinary Shares. Show more
- F2
- The term "RMB Shares" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange (the "STAR Offering"), to permitted investors in Renminbi ("RMB") within the People's Republic of China ("PRC") in accordance with the rules of the STAR Market. Show more
- F3
- The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924). Show more
- F4
- The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose. Show more
- F5
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024. Show more
- F6
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.78 to $188.64, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
- F7
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.85 to $189.81, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
- F8
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.85 to $190.82, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
- F9
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.86 to $191.57, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
- F10
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.89 to $192.17, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
Related filings at BeiGene Ltd
Institutional Holders
13F holders · Jun 30, 2026
283
institutional managers reporting a position
Largest by reported value
- Baker Bros. Advisors Lp $2.51B
- Primecap Management Co/Ca/ $1.43B
- Capital International Investors $1.2B
5%+ Holders · 13D/G
2 filers
-
Hhlr Advisors, Ltd. 4.9%
Other insiders at BeiGene Ltd
-
Xiaodong Wang -$10.9M
-
Chan Henry Lee -$418K
-
Xiaodong Wang -$11.3M
-
Xiaodong Wang -$13.4M
GET /v1/forms/4/0001651308-24-000112
API docs
View Original SEC Filing